P

Inventor

NAKADA TAKASHI

22 patents
⚠️ This page may combine multiple inventors who share the name “NAKADA TAKASHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAIICHI SANKYO CO LTD

15 patents
US10195288B2Feb 5, 2019

Antibody-drug conjugate

DAIICHI SANKYO CO LTD43 citations98
US9808537B2Nov 7, 2017

Antibody-drug conjugate

DAIICHI SANKYO CO LTD44 citations98
US10729782B2Aug 4, 2020

Antibody-drug conjugate produced by binding through linker having hydrophilic structure

DAIICHI SANKYO CO LTD18 citations94
US10155821B2Dec 18, 2018

Anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD17 citations94
US9872924B2Jan 23, 2018

Antibody-drug conjugate produced by binding through linker having hydrophilic structure

DAIICHI SANKYO CO LTD36 citations94
US10973924B2Apr 13, 2021

Antibody-drug conjugate

DAIICHI SANKYO CO LTD9 citations86
US11795236B2Oct 24, 2023

Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD6 citations85
US11633493B2Apr 25, 2023

Antibody-drug conjugate

DAIICHI SANKYO CO LTD1 citations73
US11584800B2Feb 21, 2023

Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate

DAIICHI SANKYO CO LTD2 citations73
US12246196B2Mar 11, 2025

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines

DAIICHI SANKYO CO LTD1 citations72
US11628223B2Apr 18, 2023

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines

DAIICHI SANKYO CO LTD1 citations71
US11583590B2Feb 21, 2023

Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor

DAIICHI SANKYO CO LTD1 citations71
US12186310B2Jan 7, 2025

Antibody-drug conjugate

DAIICHI SANKYO CO LTD0 citations62
US12350344B2Jul 8, 2025

Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate

DAIICHI SANKYO CO LTD0 citations60
US11185594B2Nov 30, 2021

(Anti-HER2 antibody)-drug conjugate

DAIICHI SANKYO CO LTD0 citations52

B AI KK

3 patents

TOSHIBA KK

2 patents

TOKYO SEIMITSU CO LTD

1 patent

KYOSAN DENKI KK

1 patent